Accelerating cancer screening

Ended Project Grant Awarded Last action

Award ID
H8I48980
Recipient
Awarding agency
Obligated
$1,000,000

Award facts

Assistance listing
93.224 Health Center Program
Completion date
Funding agency
Bureau of Primary Health Care Health Resources and Services Administration, Department of Health and Human Services
Place of performance
Bay City, TX 77414, USA

Award details come from USAspending.gov.

Description

Abstract
Accelerating cancer screening in matagorda and wharton counties mehop - H80CS12889 mehop has chosen to focus on colorectal cancer screening and education as well as a focus on screening for cancer and education for prostate for the (FY) 2022 accelerating cancer screening (AXCS) funding opportunity under the health center program. Mehop's collaborative partner is university of texas MD anderson cancer center ( MD anderson). MD anderson is the premier cancer center in the united states. Through a focused effort including education, outreach, screening and care management by dedicated staff for colorectal cancer screening projection for year end 2023 is 2000 adults 50 to 74 years of age will have had the potential to be screened through the collaboration of mehop and MDA. Of 2000 adults, the projection is 1400 will be screened or 70%. Prior to 2022, there has been a lack of focus and ownership by identified staff. Mehop projects to assist 18 patients with abnormal results within 30 days utilizing our gastroenterologist. This is based on a 50% increase in number of positives ( 12 is the base) which reflects a 50% increase in number screened ( increase from 225 to 337 screened). Through a focused effort including education, outreach, screening and care management by dedicated staff for prostate cancer screening for prostate cancer screening mehop will increase knowledge of screening for prostate to all patients and those community members who attend outreach events for education/screening. The projection for the number of people provided education will be 1200. The projection of increased screening will be 15% of 1200 or 180 patients screened. Mehop had over 770 patients in our system (including behavioral health, dental, ophthalmology, medical) 55 and over identified as male. Our rate of patients having PSA screening is at 7% for 2021. With the partnership of MDA, mehop will assist every patient identified with a positive P SA within 30 days to determine next steps up to and including a confirmed diagnosis of prostate cancer through recent success with HPV screening as well as remote patient monitoring, we have proven record of high level of achievement when specific staff are assigned to the specific quality initiatives. Mehop has included a MOU from university of texas MD anderson cancer center (MDANDERSON). MDANDERSON is a NCI-designated cancer center.

Transactions

Action Obligated Date
Amendment $0
Amendment $500,000
Original award $500,000

Quick answers

Who received award H8I48980?

H8I48980 was awarded to Matagorda Episcopal Health Outreach Program Corporation by Office of Federal Assistance Management (Health Resources and Services Administration) on February 1, 2023.

How much is award H8I48980 worth?

$1,000,000 has been obligated on H8I48980.

Which agency awarded H8I48980?

Office of Federal Assistance Management (Health Resources and Services Administration) awarded H8I48980, with funding from Bureau of Primary Health Care (Health Resources and Services Administration).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award